Global Medical Financials

GMRE

Source SEC Filings (10-K/10-Q) Updated Sep 30, 2025 Currency USD FYE December

This page shows Global Medical (GMRE) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 13 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Financial Health Signals

Piotroski F-Score Neutral

4/9

Global Medical passes 4 of 9 financial strength tests. 3 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass, neither operating efficiency signal passes.

Earnings Quality Cash-Backed

10.47x

For every $1 of reported earnings, Global Medical generates $10.47 in operating cash flow ($70.0M OCF vs $6.7M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Key Financial Metrics

Export CSV

Revenue

$138.8M

YoY-1.6%

5Y CAGR+14.4%

10Y CAGR+80.4%

Global Medical generated $138.8M in revenue in fiscal year 2024. This represents a decrease of 1.6% from the prior year.

EBITDA

N/A

Free Cash Flow

N/A

Net Income

$6.7M

YoY-69.2%

5Y CAGR-6.9%

Global Medical reported $6.7M in net income in fiscal year 2024. This represents a decrease of 69.2% from the prior year.

EPS (Diluted)

$0.01

Global Medical earned $0.01 per diluted share (EPS) in fiscal year 2024. This represents a decrease of 95.7% from the prior year.

Cash & Debt

$6.8M

YoY+433.3%

5Y CAGR+19.8%

10Y CAGR+39.8%

Global Medical held $6.8M in cash against $14.4M in long-term debt as of fiscal year 2024.

Dividends Per Share

$0.84

Global Medical paid $0.84 per share in dividends in fiscal year 2024. This represents an increase of 0.0% from the prior year.

Shares Outstanding

13M

Global Medical had 13M shares outstanding in fiscal year 2024. This represents a decrease of 79.6% from the prior year.

Gross Margin

N/A

Operating Margin

N/A

Net Margin

4.8%

YoY-10.6pp

5Y CAGR-8.7pp

10Y CAGR+176.3pp

Global Medical's net profit margin was 4.8% in fiscal year 2024, showing the share of revenue converted to profit. This is down 10.6 percentage points from the prior year.

Return on Equity

1.3%

YoY-2.5pp

5Y CAGR-1.0pp

Global Medical's ROE was 1.3% in fiscal year 2024, measuring profit generated per dollar of shareholder equity. This is down 2.5 percentage points from the prior year.

R&D Spending

N/A

Share Buybacks

N/A

Capital Expenditures

N/A

GMRE Income Statement

Metric	FY24	FY23	FY22	FY21	FY20	FY19
Revenue	$138.8M-1.6%	$141.0M+2.7%	$137.3M+18.4%	$115.9M+23.7%	$93.7M+32.5%	$70.7M
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$21.1M+25.3%	$16.9M+1.9%	$16.5M+0.6%	$16.5M+37.9%	$11.9M+82.6%	$6.5M
Operating Income	N/A	N/A	N/A	N/A	N/A	N/A
Interest Expense	$28.7M-7.1%	$30.9M+22.4%	$25.2M+28.1%	$19.7M+5.4%	$18.7M+6.9%	$17.5M
Income Tax	N/A	N/A	N/A	N/A	N/A	N/A
Net Income	$6.7M-69.2%	$21.7M+8.7%	$20.0M+9.0%	$18.3M+834.0%	-$2.5M-126.1%	$9.6M
EPS (Diluted)	$0.01	$0.23+15.0%	$0.20+5.3%	$0.19+211.8%	$-0.17-270.0%	$0.10

Metric	Q3'25	Q2'25	Q1'25	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23
Revenue	$37.2M-1.9%	$38.0M+9.7%	$34.6M-1.5%	$35.2M+2.7%	$34.2M-2.5%	$35.1M+6.5%	$33.0M-7.2%	$35.5M
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$4.9M-19.3%	$6.0M+66.4%	$3.6M-53.0%	$7.7M+67.9%	$4.6M+3.2%	$4.4M+5.4%	$4.2M-3.4%	$4.4M
Operating Income	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Interest Expense	$8.2M+2.1%	$8.0M+11.7%	$7.2M-5.3%	$7.6M+8.3%	$7.0M+1.5%	$6.9M-1.3%	$7.0M-2.6%	$7.2M
Income Tax	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Income	-$5.1M-964.6%	$585K-84.3%	$3.7M+27.2%	$2.9M+250.6%	-$2.0M-184.4%	$2.3M+320.0%	$551K-88.6%	$4.8M
EPS (Diluted)	$-0.45	$-0.01	N/A	$-0.09	$-0.05-600.0%	$0.01+200.0%	$-0.01-120.0%	$0.05

GMRE Balance Sheet

Metric	FY24	FY23	FY22	FY21	FY20	FY19
Total Assets	$1.3B-0.9%	$1.3B-9.0%	$1.4B+10.3%	$1.3B+14.8%	$1.1B+24.4%	$884.9M
Current Assets	N/A	N/A	N/A	N/A	N/A	N/A
Cash & Equivalents	$6.8M+433.3%	$1.3M-68.2%	$4.0M-44.3%	$7.2M+31.0%	$5.5M+99.2%	$2.8M
Inventory	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	$7.4M+9.8%	$6.8M-15.9%	$8.0M+32.5%	$6.1M+8.5%	$5.6M+12.9%	$5.0M
Goodwill	$5.9M0.0%	$5.9M0.0%	$5.9M0.0%	$5.9M0.0%	$5.9M	$0
Total Liabilities	$700.6M+5.8%	$661.9M-11.1%	$744.2M+18.9%	$625.9M-2.7%	$643.1M+51.5%	$424.6M
Current Liabilities	N/A	N/A	N/A	N/A	N/A	N/A
Long-Term Debt	$14.4M	N/A	N/A	N/A	N/A	N/A
Total Equity	$534.1M-8.5%	$583.6M-7.8%	$633.0M+1.6%	$622.8M+40.0%	$444.8M+3.4%	$430.3M
Retained Earnings	-$293.7M-22.9%	-$239.0M-20.3%	-$198.7M-26.6%	-$157.0M-34.5%	-$116.8M-63.6%	-$71.4M

Metric	Q3'25	Q2'25	Q1'25	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23
Total Assets	$1.3B-1.8%	$1.3B+2.2%	$1.3B+1.0%	$1.3B+1.2%	$1.2B-1.8%	$1.3B-0.3%	$1.3B-2.7%	$1.3B
Current Assets	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cash & Equivalents	$7.1M+8.3%	$6.6M+21.6%	$5.4M-20.6%	$6.8M+36.9%	$5.0M+273.4%	$1.3M+4.3%	$1.3M-0.2%	$1.3M
Inventory	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	$7.9M+1.5%	$7.8M-3.4%	$8.1M+9.2%	$7.4M-8.0%	$8.1M+4.3%	$7.7M+14.5%	$6.8M-10.2%	$7.5M
Goodwill	$5.9M0.0%	$5.9M0.0%	$5.9M0.0%	$5.9M0.0%	$5.9M0.0%	$5.9M0.0%	$5.9M0.0%	$5.9M
Total Liabilities	$767.4M-0.6%	$771.9M+5.5%	$731.5M+4.4%	$700.6M+5.7%	$662.8M-0.5%	$666.5M+0.7%	$661.9M-1.0%	$668.9M
Current Liabilities	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Long-Term Debt	$1.2M-91.9%	$14.2M-0.7%	$14.3M-1.1%	$14.4M-1.8%	$14.7M-43.0%	$25.7M	N/A	N/A
Total Equity	$485.3M-3.6%	$503.2M-2.7%	$517.4M-3.1%	$534.1M-4.0%	$556.4M-3.2%	$575.0M-1.5%	$583.6M-4.6%	$611.4M
Retained Earnings	-$332.6M-5.1%	-$316.5M-3.5%	-$305.7M-4.1%	-$293.7M-9.2%	-$268.9M-6.7%	-$252.0M-5.4%	-$239.0M-6.5%	-$224.4M

GMRE Cash Flow Statement

Metric	FY24	FY23	FY22	FY21	FY20	FY19
Operating Cash Flow	$70.0M+2.3%	$68.4M-10.6%	$76.5M+11.0%	$69.0M+99.8%	$34.5M-5.2%	$36.4M
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	-$45.9M-167.9%	$67.6M+149.3%	-$137.3M+29.5%	-$194.7M+13.0%	-$223.7M+13.4%	-$258.2M
Financing Cash Flow	-$21.9M+84.8%	-$143.8M-330.4%	$62.4M-51.1%	$127.7M-33.7%	$192.7M-14.0%	$224.1M
Dividends Paid	$5.8M0.0%	$5.8M0.0%	$5.8M0.0%	$5.8M0.0%	$5.8M0.0%	$5.8M
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q3'25	Q2'25	Q1'25	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23
Operating Cash Flow	$17.6M-20.7%	$22.1M+80.4%	$12.3M-40.2%	$20.5M+8.4%	$18.9M+32.4%	$14.3M-21.1%	$18.1M+8.8%	$16.7M
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	-$703K+98.2%	-$39.2M-44.1%	-$27.2M-39.4%	-$19.5M-1193.7%	$1.8M+165.7%	-$2.7M+12.8%	-$3.1M-155.0%	$5.7M
Financing Cash Flow	-$16.2M-186.8%	$18.7M+37.7%	$13.6M+8787.6%	$153K+100.7%	-$20.7M-97.2%	-$10.5M+34.0%	-$15.9M+35.1%	-$24.5M
Dividends Paid	$1.5M-0.1%	$1.5M+0.1%	$1.5M-0.1%	$1.5M0.0%	$1.5M+0.1%	$1.5M-0.1%	$1.5M+0.1%	$1.5M
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

GMRE Financial Ratios

Metric	FY24	FY23	FY22	FY21	FY20	FY19
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	N/A	N/A	N/A	N/A	N/A	N/A
Net Margin	4.8%-10.6pp	15.4%+0.8pp	14.6%-1.3pp	15.8%+18.5pp	-2.7%-16.2pp	13.6%
Return on Equity	1.3%-2.5pp	3.7%+0.6pp	3.2%+0.2pp	2.9%	N/A	2.2%
Return on Assets	0.5%-1.2pp	1.7%+0.3pp	1.4%-0.0pp	1.5%+1.7pp	-0.2%-1.3pp	1.1%
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A
Debt-to-Equity	0.03-1.1	1.13-0.0	1.18+0.2	1.00-0.4	1.45+0.5	0.99
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q3'25	Q2'25	Q1'25	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Margin	-13.6%-15.1pp	1.5%-9.3pp	10.8%+2.4pp	8.4%+14.1pp	-5.7%-12.3pp	6.6%+4.9pp	1.7%-11.9pp	13.6%
Return on Equity	N/A	0.1%-0.6pp	0.7%+0.2pp	0.5%	N/A	0.4%+0.3pp	0.1%-0.7pp	0.8%
Return on Assets	-0.4%-0.5pp	0.1%-0.2pp	0.3%+0.1pp	0.2%+0.4pp	-0.2%-0.3pp	0.2%+0.1pp	0.0%-0.3pp	0.4%
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Debt-to-Equity	0.00-0.0	0.030.0	0.030.0	0.030.0	0.03-0.0	0.04-1.1	1.13+0.0	1.09
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Similar Companies

Diversified Healthcare Tr DHC

$1.6B

Sila Realty Trust Inc SILA

$1.4B

Strawberry Field STRW

$166.4M

Ltc Properties LTC

$1.9B

Universal Health UHT

$590.3M

Frequently Asked Questions

What is Global Medical's annual revenue?

Global Medical (GMRE) reported $138.8M in total revenue for fiscal year 2024. This represents a -1.6% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Global Medical's revenue growing?

Global Medical (GMRE) revenue declined by 1.6% year-over-year, from $141.0M to $138.8M in fiscal year 2024.

Is Global Medical profitable?

Yes, Global Medical (GMRE) reported a net income of $6.7M in fiscal year 2024, with a net profit margin of 4.8%.

What is Global Medical's earnings per share (EPS)?

Global Medical (GMRE) reported diluted earnings per share of $0.01 for fiscal year 2024. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

How much debt does Global Medical have?

As of fiscal year 2024, Global Medical (GMRE) had $6.8M in cash and equivalents against $14.4M in long-term debt.

What is Global Medical's net profit margin?

Global Medical (GMRE) had a net profit margin of 4.8% in fiscal year 2024, representing the share of revenue converted into profit after all expenses.

Does Global Medical pay dividends?

Yes, Global Medical (GMRE) paid $0.84 per share in dividends during fiscal year 2024.

What is Global Medical's return on equity (ROE)?

Global Medical (GMRE) has a return on equity of 1.3% for fiscal year 2024, measuring how efficiently the company generates profit from shareholder equity.

What is Global Medical's operating cash flow?

Global Medical (GMRE) generated $70.0M in operating cash flow during fiscal year 2024, representing cash generated from core business activities.

What are Global Medical's total assets?

Global Medical (GMRE) had $1.3B in total assets as of fiscal year 2024, including both current and long-term assets.

How many shares does Global Medical have outstanding?

Global Medical (GMRE) had 13M shares outstanding as of fiscal year 2024.

What is Global Medical's debt-to-equity ratio?

Global Medical (GMRE) had a debt-to-equity ratio of 0.03 as of fiscal year 2024, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Global Medical's return on assets (ROA)?

Global Medical (GMRE) had a return on assets of 0.5% for fiscal year 2024, measuring how efficiently the company uses its assets to generate profit.

What is Global Medical's Piotroski F-Score?

Global Medical (GMRE) has a Piotroski F-Score of 4 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Global Medical's earnings high quality?

Global Medical (GMRE) has an earnings quality ratio of 10.47x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.